MAP Pharmaceuticals names Scott R. Ward board of directors chairman

Tuesday, March 1, 2011 08:00 AM

MAP Pharmaceuticals has named Scott R. Ward chairman of its Board of Directors. Current Chairman Steven A. Elms will step down from the board after more than six years of service.

Most recently, Ward was senior vice president and president of the cardiovascular business of Medtronic. Previously, he was senior vice president and president of Medtronic Neurological and Diabetes, and vice president and general manager of the Medtronic Drug Delivery Business. Ward has served as a director of MAP Pharmaceuticals since 2008.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs